We are live on ! Find out more
CPA

Capital Performance Advisors Portfolio holdings

AUM $1.5B
1-Year Est. Return 21.4%
This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+21.4%
3 Year Est. Return
+61.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$313M
AUM Growth
-$16.2M
Cap. Flow
-$18.2M
Cap. Flow %
-5.83%
Top 10 Hldgs %
65.31%
Holding
2,902
New
5
Increased
124
Reduced
24
Closed
2,725

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.37M
2
VTI icon
Vanguard Total Stock Market ETF
VTI
+$920K
3
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$725K
4
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$662K
5
AAPL icon
Apple
AAPL
+$578K

Top Sells

Rank Stock Value
1
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$518K
2
JNJ icon
Johnson & Johnson
JNJ
+$318K
3
IWM icon
iShares Russell 2000 ETF
IWM
+$273K
4
AMD icon
Advanced Micro Devices
AMD
+$212K
5
CI icon
Cigna
CI
+$201K

Sector Composition

Rank Sector Weight
1 Technology 11.18%
2 Financials 3.82%
3 Consumer Discretionary 2.43%
4 Communication Services 1.88%
5 Healthcare 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVBP icon
2776
ArriVent BioPharma
AVBP
$1.4B
– –
-67
Closed -$1.57K
BTSG icon
2777
BrightSpring Health Services
BTSG
$14.1B
– –
-39
Closed -$573
AS icon
2778
Amer Sports
AS
$20.5B
– –
-74
Closed -$1.18K
ANRO icon
2779
Alto Neuroscience
ANRO
$1.08B
– –
-4
Closed -$46
ARQ icon
2780
Arq
ARQ
$85.4M
– –
-31
Closed -$182
GUTS icon
2781
Fractyl Health
GUTS
$127M
– –
-67
Closed -$170
STI icon
2782
Solidion Technology
STI
$56.4M
– –
0
– –
KYTX icon
2783
Kyverna Therapeutics
KYTX
$481M
– –
-8
Closed -$39
MGX icon
2784
Metagenomi Therapeutics
MGX
$45.6M
– –
-5
Closed -$11
TELO icon
2785
Telomir Pharmaceuticals
TELO
$84.6M
– –
-22
Closed -$141
PRKS icon
2786
United Parks & Resorts
PRKS
$2.12B
– –
-8
Closed -$405
TVGN icon
2787
Tevogen Bio Holdings
TVGN
$23.5M
– –
-9
Closed -$175
ASTH icon
2788
Astrana Health
ASTH
$1.89B
– –
-12
Closed -$695
MTUS icon
2789
Metallus
MTUS
$869M
– –
-44
Closed -$653
CRML icon
2790
Critical Metals Corp
CRML
$887M
– –
-45
Closed -$335
ALAB icon
2791
Astera Labs
ALAB
$48.4B
– –
-10
Closed -$524
LENZ
2792
LENZ Therapeutics
LENZ
$179M
– –
-6
Closed -$142
CPAY icon
2793
Corpay
CPAY
$24.8B
– –
-29
Closed -$8.96K
GCTS
2794
GCT Semiconductor Holding
GCTS
$180M
– –
-61
Closed -$204
BOLD
2795
Boundless Bio
BOLD
$55.7M
– –
-42
Closed -$146
SOLV icon
2796
Solventum
SOLV
$13.9B
– –
-703
Closed -$49K
GEV icon
2797
GE Vernova
GEV
$265B
– –
-345
Closed -$88K
PACS icon
2798
PACS Group
PACS
$7.45B
– –
-2
Closed -$80
CTRI icon
2799
Centuri Holdings
CTRI
$2.76B
– –
-10
Closed -$162
IBTA icon
2800
Ibotta
IBTA
$638M
– –
-1
Closed -$62
110 111
112
113 114

Similar funds

SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Capital Performance Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Capital Performance Advisors held 2,902 positions worth $313M, down 4.9% from $329M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Capital Performance Advisors withdrew a net $18.2M in Q4 2024, closing 2,725 positions and reducing 24 holdings. Its most notable exit was Johnson & Johnson, an estimated $318K position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Capital Performance Advisors added an estimated $1.37M to NVIDIA.

  • Capital Performance Advisors added most to NVIDIA in Q4 2024, an estimated $1.37M increase.
  • Capital Performance Advisors's biggest Q4 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $518K.
  • Capital Performance Advisors fully exited Johnson & Johnson in Q4 2024, selling an estimated $318K.
  • Capital Performance Advisors's ten largest holdings make up 65% of its $313M portfolio in Q4 2024.
  • Capital Performance Advisors opened 5 new positions and closed 2,725 in Q4 2024.
  • Capital Performance Advisors's portfolio value fell 4.9% quarter-over-quarter to $313M.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.